Sona Nanotech

Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") of which 1,855,0000 have been granted to Directors and Officers. Each option is exercisable into one common share at a price of $0.30 per share and will vest at the rate of 25% every six months.» Mehr auf newsfilecorp.com

Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) chief medical officer Dr Carman Giacomantonio talked with Proactive about the company's latest findings related to its targeted hyperthermia therapy (THT), which he described as showing “very enabling immunogenic” effects in recent experiments. The THT platform works by delivering controlled heat to the core of a tumour, triggering a natural cell death response and activating the body's immune system.» Mehr auf proactiveinvestors.com

From potential changes in government healthcare policies to persistent inflationary pressures and evolving investment strategies, the US healthcare sector is facing a convergence of economic, regulatory, and political forces that could reshape the industry's trajectory for years to come. As the industry emerges from the lingering effects of the COVID-19 pandemic, healthcare companies must adapt to new cost structures, shifting reimbursement models, and an increasingly competitive landscape.» Mehr auf proactiveinvestors.com